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Abstract 
 
PURPOSE: Fibromyalgia (FM) is typically associated with the experience of diffuse pain and 
physical impairment. Depression also commonly co-exists in patients with FM, and has been 
correlated with pain intensity and physical functioning. Previous research suggests an association 
between pain intensity and physical functioning; however, the direct causal relationship between 
improvements in pain intensity and in functioning is not observed in many FM patients. This 
may suggest that another factor such as depression is mediating this relationship. The present 
work examined mediating role of depression. METHODS: 216 patients with FM completed 
measures of pain intensity, depression, and physical function as part of a larger longitudinal 
study. Assessments were completed at baseline, 12, 24, and 36 weeks. RESULTS: Longitudinal 
mediational analyses indicated that depression is a partial mediator of the relationship between 
pain intensity and physical functioning at all four assessment points. Beta coefficients for the 
path from pain to physical functioning ranged from 0.18 – 0.36, with attenuated path coefficients 
ranging from 0.03 – 0.08, still showing significant but decreased associations when depression 
was added as a mediator.  CONCLUSIONS: Clinical implication includes the importance of 
treating co-morbid depression in patients with fibromyalgia early in the course of treatment to 















Fibromyalgia (FM) is a chronic pain condition characterized by persistent diffuse 
musculoskeletal pain, fatigue, and non-restorative sleep (Wolfe, Ross, Anderson, Russell, & 
Hebet, 1995), diagnosed on the basis of self-reported symptoms, as there are no biological 
markers specific to the condition (Wolfe et al, 2011). Recent prevalence rates suggest the 
condition affects approximately 2.1% of the general population and is more common among 
women (Wolfe, Brähler, Hinz, & Häuser, 2013). Partly because of the subjective nature of 
diagnosing FM, patients often do not receive validation of their pain from those around them. As 
a result, FM patients may feel isolated, misunderstood, or rejected by loved ones and society 
(Turk, 2002), which may contribute to the experience of depression.  
Physical Functioning and Pain 
Decreases in physical functioning are among the most problematic symptoms for FM 
patients (Bennett, Jones, Turk, Russel, & Matallana, 2007; Turk et al, 2008). A survey of 1735 
women with FM found that 25% reported experiencing difficulty completing activity of daily 
living such as bathing, and 90% reported trouble with heavy household tasks and strenuous 
activities (Jones, Rutledge, Jones, Matallana, & Rooks, 2008). Bennett and colleagues (2007) 
found that a mere 7% of their sample reported being able to complete tasks such as vacuuming or 
scrubbing.  
 Declines in physical functioning seem to be correlated with severity of FM pain (Kop et 
al, 2005). Studies have documented pain intensity as a significant predictor of physical 
functioning among fibromyalgia patients (Bigatti, Hernandez, Cronan, & Rand, 2008).  
Despite the documented relationship between pain and functioning, both pharmacological 
and non-pharmacological interventions aimed at improving physical functioning do not yield 
consistent positive changes in pain intensity (Häuser, Petzke, & Sommer, 2010). The 
inconsistencies in the relationships between changes in physical functioning and pain intensity 
suggest that there may be mediating variables, such as psychological factors, underlying the 
relationship between pain and physical functioning. This relationship is further complicated by 
the fact that research demonstrates improvements in physical functioning may in turn create 
reductions in pain intensity due to reversing or prevention of deconditioning and disuse; 
however, patients may have difficulty breaking this cycle of perpetuating pain and lack of 
activity due to pain as well as depression and other psychological factors (Scott, Kroenke, Wu & 
Yu, 2016). This is further supported by meta-analytic work indicating that psychological 
interventions produce the largest improvements in daily functioning (Bernardy, Klose, Busch, 
Choy, & Häuser, 2013), as well as improvements in pain-related behaviors, and psychological 
factors (Bennett & Nelson, 2006). 
The Role of Depression 
Co-morbid depression is common among individuals with FM (Gormsen, Rosenberg, 
Bach, & Jensen, 2010; Thieme, Turk, & Flor, 2007) with estimated prevalence rates between 24-
40% (Bennett et al, 2007; Munce and Stewart, 2007). Further, Munce and Stewart (2007) have 
reported higher rates of comorbid depression in FM (22.3%) compared to other chronic pain 
conditions such as rheumatoid arthritis (10%) and chronic back pain (12.6%).  
The reasons behind the large rates of depression in FM populations are varied. It is not 
surprising that the experience of chronic pain would lead some individuals to experience 
depression when contemplating the chronic nature of their condition and the limitations it entails 
(Harris, Morley, & Barton, 2003). Although depression may lead to more pain among chronic 
pain patients, longitudinal research demonstrates that chronic illness leads to depression, and not 
the other way around. Chronic pain specifically has been identified as a risk factor for depression 
and prolonged depressive episodes in the general population (Ohayon & Schatzberg, 2003). 
Using ecological momentary assessments, Okifuji, and colleagues (2011) sequenced daily 
symptoms in FM and found that pain preceded and increased emotional distress. 
For depressed FM patients, reductions in physical functioning are compounded. Okifuji 
et al (2000) found that depressed patients reported greater impairment in household tasks and 
physical activities outside of the home and higher levels of perceived disability than those FM 
patients without depression.  
These findings suggest that depression may mediate the relationship between pain and 
physical functioning in chronic pain populations. Wegener and colleagues (2011), found in limb 
trauma patients that psychological distress mediated pain and function, and similar relationships 
with psychological mediators have been noted in other pain populations as well (Craig, Tran, 
Siddall, Wijesuriya, Lovas, Bartrop, & Middleton, 2013; Kop et al, 2005; Peters, Vlaeyen, & 
Weber, 2004). Specific to FM, many studies have examined potential mediators of pain and 
functioning. For example, Miró and colleagues (2011) found that sleep quality mediated the 
relationship between pain and emotional distress, as well as pain and physical functioning, 
suggesting a possible relationship between distress and physical functioning via sleep, and other 
studies have suggested that variables related to depression such as catastrophic thinking about 
pain (Crombez et al, 2004) may play a role.  Additionally, exercise interventions for 
Fibromyalgia have suggested positive correlations between improvements in depression and 
increased activity (Gowans, deHueck, Voss, Silaj, Abbey, & Reynolds, 2001; Tomas-carus et al, 
2008). However, we could not find any study that explicitly examined depression as a statistical 
mediator of the pain and physical functioning relationship. Given that depression is so prevalent 
in FM, and so disruptive to quality of life, it is important to consider its role in the relationship 
between pain and functioning. 
 In a sample of FM patients we hypothesized that pain, depression and physical 
functioning would be correlated. We expected that depression would mediate the relationship 
between pain intensity and physical functioning across multiple time points.  
Materials and Methods 
Design 
This is a secondary data analysis of a completed randomized controlled trial entitled, 
Research to Encourage Exercise in Fibromyalgia (REEF) (Ang et al, 2013). The study approved 
by the university Institutional Review Board, examined motivational interviewing as an 
intervention to enhance physical activity in patients with Fibromyalgia; no effects of the 
intervention were found (Ang et al, 2011). As part of a battery of questionnaires self-report 
measures of pain intensity, physical functioning, and depression collected and completed at 4 
time points: baseline, immediately following an intervention period (12 weeks), 3- month follow-
up (24 weeks), and 6- month follow-up (36 weeks). All four assessment points were examined to 
test our hypotheses. 
Participants  
Participants were recruited from various primary care clinics or specialty medicine 
practices (rheumatology, pain management, and neurology). To be eligible to participate in the 
study, individuals were required to meet the following inclusion criteria: 1) must be between 18-
65 years of age, 2) must be diagnosed with FM by a board-certified rheumatologist, 3) must be 
on stable doses of all medications, and 4) must have an average pain level of 4 or above on a 
scale from 0-10. Exclusion criteria included diagnosis of another rheumatic condition such as 
rheumatoid arthritis; full exclusion criteria are described elsewhere (Ang et al, 2013). The study 
enrolled 216 FM patients. Informed consent was obtained from all participants prior to the onset 
of the study. Given that the intervention had no effects on any of the relevant variables 
participants in both the intervention and attention control arms were included in the present 
analyses as one single group. 
Measures 
Physical functioning. The Fibromyalgia Impact Questionnaire Physical Impairment 
Subscale (FIQ-PI; Burckhardt, Clark, & Bennett, 1991) consists of 10 items that focus primarily 
on the patient’s ability to perform large muscle tasks (i.e. doing yard work, vacuuming a rug) in 
the week leading up to the assessment, presented in a Likert-type scale format ranging from 0 
(always able to do) to 3 (never able to do). The sum of these 10 items is divided by the number 
of valid scores and then multiplied by 3.33 to provide one physical impairment score that ranges 
from 0-9.99. The items are specific to ability over the past week. The scale has demonstrated 
test-retest reliability (0.56 to 0.95). Both content and construct validity have previously been 
established [29]. It should be noted that this is the original version of the scale. 
Depression. The Personal Health Questionnaire Depression Scale (PHQ-8) is an eight 
item self-report measure designed to assess depressive symptoms over the two week period 
leading up to the assessment (Kroenke, Strine, Spitzer, Williams, Berry, & Mokdad, 2009). The 
eight items are designed to map onto the diagnostic criteria for a depressed episode in the DSM-
IV-TR, with the exception of suicidal ideation. The measure is short and easy to score, making it 
an ideal measure for both patients and clinicians to use. Scores range from 0-24 with lower 
scores representing milder levels of depression. Additionally, the measure has specified cut-off 
scores for various levels of symptom severity: (0-4 = minimal; 5-9 = mild; 10-14 = moderate; 
15-19 = moderately severe; ≥20= severe). 
Pain. The Brief Pain Inventory (BPI; Cleeland, 1989) is a self-report measure designed to 
assess pain on two dimensions: pain intensity and pain interference. The BPI pain intensity is an 
average of 4 items (i.e., worse pain, least amount of pain, average pain and pain right now) that 
ask participants to rate their pain on a scale of 0-10 (0= no pain and 10 = pain as bad as you can 
imagine) during the past 7 days. For the present study, only the BPI pain intensity domain was 
examined. Higher scores are associated with greater levels of pain. 
Statistical Analyses 
Longitudinal mediation analyses were performed to determine if the association between 
pain and physical function is mediated by depression. First, Structural Equation Modeling (SEM) 
techniques were used to set up the longitudinal design; at each time period, direct effect paths 
were tested from pain to depression and depression to function. An indirect path between pain 
and function was tested at each time point as well, so that both the direct and indirect effects 
were evaluated to determine the presence of mediation. The longitudinal aspect was analyzed by 
adding paths between the variables from each time point to the next follow-up (i.e. from pain at 
baseline to week 12, pain from week 12 to week 24, and pain from week 24 to week 36, with 
similar paths for the associations between depression outcomes and physical function outcomes). 
The model was also adjusted for treatment group: Motivational Interviewing intervention to 
enhance physical activity engagement (MI) vs. an educational attention control intervention 
(AC), with treatment group having paths leading to the functional outcome at each time point 
(MacKinnon, 2008). Although the sample size necessary for such a model is relatively large, due 
to the number of paths and parameters, bootstrapping methods were used to resample the data in 
order to more accurately estimate the parameters, including path coefficients. To further clarify 
the longitudinal relationships, a second model, where paths were added from both pain and 
depression to the next assessment’s function outcome, was also performed. The longitudinal 
mediation analysis was performed using Mplus software and is consistent with modeling 
outlined by Muthen (1997). 
Results 
Descriptive Statistics 
Participants were 216 individuals with FM, of which 95.8% were female.  The average 
age of participants was 45.81 (SD = 11.18), and the average number of years since diagnosis 
with FM was 9.01 year (SD = 7.02).  A complete description of the participant characteristics is 
presented in Table 1.   
Physical Functioning 
 As a group, the level of impairment in physical functioning at baseline was moderate 
with a group FIQ-PI mean score of 5.37 (SD = 1.57) at baseline.  However scores ranged from 
2.12-9.99 indicating that for some individuals the level of functional impairment was very 
severe.  Of the specific tasks listed on the FIQ-PI, washing dishes, vacuuming, walking several 
blocks, and yard work had the highest group means for difficulty.  Across all visits, FIQ-PI 
ranged from 0 to 9.99, with follow-up visits having mean scores just under four (3.86, 3.93, and 
3.80).  Means, standard deviations, and ranges of scores for all assessment time points can be 
seen in Table 2. 
Pain Intensity 
 The mean baseline score for pain intensity on the BPI was 5.95 (SD = 1.27), with scores 
ranging from 0.25 to 10 throughout the study, with mean BPI values close to five across the 
study time (4.90, 5.05, and 4.71 at the three follow-up visits, respectively).  Pain intensity scores 
ranged from 4-10, with 78.2% rating their pain as 5 or greater, and 7.9% rating their pain as an 8 
or above indicated very severe level of pain.  The most commonly reported amount of pain was a 
rating of 5.5, accounting for 9.3% of the sample. Means, standard deviations, and ranges of 
scores for all assessment time points can be seen in Table 2. 
Depression 
 The mean score on the PHQ-8 at baseline was 12.54 (SD = 4.92), ranging from 0 – 24 
across the study, and with mean values at follow-up visits staying between 9 and 10 (9.33, 9.77, 
and 9.81, respectively), which represents a moderate level of depression for the group as a 
whole.  Scores ranged from 1-24 indicating that our sample varied greatly with respect to 
depressive symptoms. The most frequently endorsed items were related to energy level and/or 
sleeping. A very small portion of the sample (3.2%) reported a minimal level of depression, and 
a slightly larger but still small percent (6.9%) reported a severe level of depression; the majority 
of the sample fell somewhere in the middle of the continuum. Means, standard deviations, and 
ranges of scores for all assessment time points can be seen in Table 2. 
Mediational Analyses 
Using the structural equation modeling approach described above, we tested the mediating 
role of depression in the relationship between pain intensity and physical functioning using 
longitudinal data.  Model 1 analyzed each mediation cross-sectionally, while adjusting for each 
variable’s measure at the previous time point (i.e., depression at 12 week visit was adjusted for 
by depression at baseline); additionally, these relationships were tested adding longitudinal steps 
to functioning, at each visit, from the previous visit’s pain and depression outcomes (Model 2).  
Figure 1 provides an illustration of the model and the beta weights for each path and Table 3 
includes beta weights for all paths.  In both models, the effect of treatment group was added, 
with paths to each visit’s functioning outcome.  Overall, beta coefficients for the path from pain 
to function ranged from 0.18 – 0.36, with attenuated path coefficients ranging from 0.03 – 0.08, 
still showing significant associations.  Beta coefficients for paths from depression to function 
ranged from 0.15 – 0.28 and from pain to depression ranged from 0.23 – 0.31.  Longitudinal 
paths, from each variable to itself at the next visit, ranged from 0.26 – 0.67, with a median 
coefficient of 0.49. 
Results of Model 1 indicated that depression is a significant partial mediator of the 
relationship between pain intensity and physical functioning at all four time points. The 
mediation is viewed as partial, given that this relationship maintained significance even in the 
presence of depression, but the strength of the relationship decreased at each point in time.  
There were significant positive associations between each outcome and its respective value at the 
next follow-up (i.e. physical functioning at baseline was associated with physical functioning at 
subsequent time points).   As stated previously, there were no significant effects of the 
intervention on the originally randomized group, thus all participants were treated as one group 
in the present analyses.  However, exploratory analyses were conducted both with and without 
treatment group and treatment group was not significantly associated with functioning.  Analyses 
were performed without treatment group yielded similar results.   
For Model 2, although depression was significantly associated with functioning at the 
following visit, for all visits, pain was not.  In addition, the main mediation analyses were not 
attenuated and remained similar to Model 1’s results.  With the added path from pain and 
depression to physical functioning at the next time point Model fit statistics (using both Akaike 
and Bayesian information criteria) showed similar results between the models, with Model 2 
having a slight, but non-significant, worse fit, due to the number of added paths.  Both models 
are presented in Figure 1. 
Additionally, both mediation models (cross-sectional and longitudinal) were run in reverse, 
looking at the association of function on pain, being mediated by depression.  Results were 
similar in both models, indicating that pain and physical functioning are significantly associated, 
with depression being a significant partial mediator, regardless of direction. 
 
Discussion 
 The aim of the present study was to examine the relationships between pain intensity, 
physical functioning, and depression in a group of FM patients and to determine the potential 
mediating effect of depression on the pain intensity- physical functioning relationship over time.  
Our findings that depression partially mediates the relationship between pain intensity and 
physical functioning support the extant literature that shows improvements in physical and 
mental health with reduced pain (Moore et al, 2010). The fact that depression emerged as only a 
partial mediator highlights the importance of pain intensity to deficits in physical functioning. 
Given that pain and physical functioning are the two most common physical symptoms and 
complaints of patients, they are, and should be, the focus on treatment planning.  
However, clinically significant pain reduction is difficult to achieve in FM. Meta-analyses 
suggest current pharmacological treatments for FM pain have small effect sizes and serious side 
effects (Häuser et al, 2014; Sebastian, Derry, Moore, & McQuay, 2010). Cognitive Behavioral 
Therapy (CBT), the most common behavioral approach to pain reduction in FM has had mixed 
results in terms of efficacy with some meta-analyses suggesting that CBT is effective for only 
short-term pain reduction (Glombieski et al 2010), or that the intervention yields only small 
effects on pain, functioning, and mood (Bernardyet al, 2013).     
Regular exercise and moderate levels of physical activity are considered to be important 
components in the management of FM (Clauw, 2014; Häuser, Thieme, & Turk, 2010).  Both 
aerobic and strength enhancing exercise yield moderate to large effects on physical functioning 
(Busch et al, 2011), and lower pain has been related to better muscle strength and flexibility 
(Soriano-Maldonado et al., 2015).  However, FM patients are often reluctant to adopt a physical 
activity program because of fear of pain and activity-avoidance beliefs (de Bruijin et al, 2011).  
This is further evidenced by the finding that the average dropout rate in clinical trials of exercise 
for FM is greater for those assigned to aerobic exercise (22%) compared to those assigned to a 
control condition (10%; Busch et al, 2011).   Thus although treatments aimed at pain and 
functioning have some effect, these findings provide compelling evidence for the need to find 
other target for treatment. One of these may be a greater focus on depressive symptoms in FM 
patients. 
Our data provide compelling evidence for emphasizing treatment of depression in the 
treatment of FM. Present results showed a significant partial mediation of the pain intensity- 
physical functioning relationship via depression across multiple assessment points. It is 
important to note that the means for each of these variables changed across assessment points, 
and strength of the relationships also changed, but the mediation of depression remained 
similarly strong at each time point. Even with the addition of longitudinal paths assessing 
associations between the same variable across time points, depression at any time point remained 
a significant partial mediator of pain intensity-physical functioning relationship at that same time 
point. The temporal directions of these relationships were tested as well, by testing in reverse 
order, yielding no significant associations and providing greater evidence for the direction of the 
relationships between variables. 
Treating depression in an effort to improve functioning may also help decrease pain, or 
perception of pain. The pain-depressive symptoms relationship has been extensively established, 
and recent research suggest a bidirectional relationship between these two experiences (Chang et 
al, 2015). However, understanding that this relationship may lead to physical functioning 
problems had not been explicitly established in FM to date.  
Depressed mood may also make patients more aware of their symptoms and more likely to 
react to these symptoms in a maladaptive manner (Wegener et al, 2011). According to Wegener 
et al. (2011), depressed mood may lead patients to more negatively appraise their abilities, or to 
avoid activities altogether, leading to lower functioning. These researchers examined individuals 
who had experienced lower limb trauma and found that depressed mood played a larger role in 
decreased functioning as time passed from the time of injury.   
Other factors associated with depression such as pain catastrophizing and low self-efficacy 
(Börsbo, Gerdle, & Peolsson, 2010) and fatigue (Lukkahatai et al., 2016) are also related to 
disability among FM and chronic pain patients, suggesting avenues through which depression 
may contribute to poorer physical functioning.   
A multidisciplinary treatment plan that also addresses depression and its impact on 
functioning may be the best approach for FM. Although guidelines for the management of FM 
have long included the use of CBT and psychological interventions, greater emphasis may need 
to be placed on psychological intervention that focus on depressive symptoms and thought 
processes in addition to maladaptive beliefs about pain, as is often the focus in most CBT for 
chronic pain interventions.  Interventions aimed at emotional expression may also be effective in 
reducing depression, pain, and pain interference (Burger et al., 2016; Lumley, 2011).   
Importantly, all the treatment modalities mentioned above, pharmacological, behavioral and 
physical activity, may work better if they are combined with a focus on reducing depressive 
symptoms along with improvements in pain and functioning.  Given our mediation findings it 
may well be that a slight change in approach, the addition of components focused on mood, may 
increase the treatment effectiveness.  
Limitations 
 An important limitation to the present study is the fact that all of the variables were 
assessed by self-report. Self-report measures are often criticized for being subject to response 
bias and inaccurate reporting (Greenwald et al, 2002). Physical functioning and pain can be 
measured in a more objective manner, such as activity monitors which have been used in other 
studies (Ang et al, 2010) to assess the experience of pain in a more objective manner. It should 
also be noted that within our sample, participants reported a mean depression score indicative of 
only moderate levels of depression; thus, it is plausible that this relationship may be more 
pronounced in a more depressed sample, though further work is needed to confirm this 
assumption. It bears mention that several other factors may play a role in explaining the 
relationship between pain intensity and physical functioning; previous research in other chronic 
pain populations has indicated that catastrophizing, fear of reinjury, and pain-related anxiety may 
impact this relationship as well (Denison, Asenlof, & Lindberg, 2004; Peters et al, 2004; Scott, 
Kroenke, Wu & Yu, 2016); and there is evidence that these factors contribute to the experience 
of depression as well (Sturgeon & Zautra, 2013).   Another plausible relationship worth 
exploring is the role of fatigue/decreased energy; fatigue is a hallmark symptom of fibromyalgia, 
with some estimates suggesting prevalence rates as high as 76% in FM patients (Vincent, Benzo, 
Whipple, McAllister, Erwin, & Saligan, 2013).  It stands to reason that fatigue may also play a 
role in the relationship between depression/negative affect and physical functioning/disability as 
it is correlated with both  (Vincent et al, 2013). Although we were unable to examine these 
factors in the present study, future research should attempt to further illustrate the complex 
relationships between psychological constructs, pain, fatigue, and functioning with FM patients; 
this work may involve looking for subgroups within the populations that exhibit various patterns 
of these other factors; this work would be especially important given the only partial mediation 
of our depression mediator. Furthermore, we cannot generalize these findings to individuals with 
different demographic characteristics than our sample, or to non-patient populations. 
Conclusions 
The present research is congruent with the existing literature on the strong relationships 
between pain intensity, physical functioning and depression. Furthermore, the data support our 
hypothesis that depression mediates the relationship between pain intensity and physical 
functioning in FM patients, and that this pattern held across multiple times points as well as 
when individual variables were assessed overtime. To our knowledge, this is the first study to 
explicitly examine this relationship in a sample of FM patients, as well as the first to do so using 
a longitudinal design. The study results significantly add to our understanding of the 
complexities behind efforts to improve physical functioning in this population. Given that our 
findings regarding the mediational role of depression in the pain intensity-physical functioning 
relationship are largely aligned with research in nonspecific chronic pain populations, coupled 
with the consistency of our findings over time, we can assume confidence in the mediational role 
of depression. Clinical implications for these findings include focusing on depression and more 
specifically psychological correlates of depression as first line therapeutic targets in improving 
physical functioning of patients with FM. Depression and other psychological factors should be 
assessed and intervened upon early in the treatment of FM, before the individual has an 
opportunity to engage in the disability cycle. 
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Demographic Characteristics of Participants 
Variable Mean SD 
Age 45.81 11.18 
Years since diagnosis 9.01 7.02 
   
Variable Percentage N 
Sex   
Female 95.8 207 
Male 4.2 9 
Race   
Caucasian 88.4 191 
African American 9.3 20 
American Indian 0.9 2 
Pacific Islander 0.5 1 
Other 0.9 2 
Education   
< High school 2.8 6 
High School or GED 19.4 42 
>High School 77.9 168 
Employment Status   
Employed 45.4 98 
Self-employed 8.3 18 
Retired 3.7 8 
Homemaker 11.6 25 
Student 4.2 9 
Unable to work 19.0 41 
Currently out of work 3.7 8 





 FIQ-PI BPI PHQ-8 
Week M (SD) Range M (SD) Range M (SD) Range 
1 5.37 (1.57) 2.12-  9.99 5.95 (1.27) 4.00 - 10.00 12.54 (4.92) 1-24 
12 3.86 (2.04) 0.00-  8.78 4.90 (1.75) 1.25 - 10.00 9.33 (5.36) 0-24 
24 3.93 (2.24) 0.00-  9.99 5.05 (1.84) 0.25 – 10.00 9.77 (5.92) 0-24 
36 3.80 (2.41) 0.00 - 9.99 4.71 (1.91) 0.25 - 9.50 9.81 (5.97) 0-24 
FIQ-PI = Fibromyalgia Impact Questionnaire- Physical Interference Subscale; BPI = Brief Pain Inventory (pain 




 Path A Path B Path C Path C’ 
Week 1 β = 0.279** β = 0.284** β = 0.177* β = 0.081* 
Week 12 β = 0.308** β = 0.270** β = 0.264** β = 0.082* 
Week 24 β = 0.236** β = 0.177* β = 0.224** β = 0.044* 
Week 36 β = 0.234** β = 0.147* β = 0.360** β = 0.034* 
*significant at p < 0.01; ** significant at p <0.001 
Path A = Direct effect of Pain Intensity on Depression; Path B = Direct effect of Depression on Physical Functioning; Path C = 
Direct effect of Pain Intensity on Physical Functioning; Path C’ = Relationship between Pain Intensity and Physical Functioning 
with Depression as a mediator.  All path coefficients are standardized, based on longitudinal analyses. 
  
 Figure 1. The mediating role of depression in the relationship between pain intensity and 
physical functioning. 
 
 
 
 
 
